Biological weapons are not new. Biological agents have been used as instruments of warfare and terror for thousands of years to produce fear and harm in bumans, animals, and plants. Because they are invisible, silent, odorless, and tasteless, biological agents may be used as an ultimate weapon-easy to disperse and inexpensive to produce. Individuals in a laboratory or research environment can be protected against potentially hazardoUs biological agents by using engineering con-troIs, good laboratory and microbiological techniques, personal protective equipment, decontamination ptocedures, and common sense. In the field or during a response to an incident, only personal protective mezsures, equipment, and decontamination procedures may be available. In either scenario, an immediate evaluation of the situation is foremost, applying risk management procedures to control the risks affecting health, safety, and the environment. The microbiologist and biological safety professional can provide with responsible offic ids a practical assessment of the biological weapons incident in order to help address microbiological and safety issues, minimize fear and concerns of those responding to the incident, and help manage individuals potentially exposed to a threat agent.
Introduction
Biological weapons derived from biological materialts) are considered weapons of mass destruction, or, Keywords: personal protection, incident response, decontamination more appropriately, as weapons of mass casualty. A biological weapon is actually a four-part system composed of a payload, munition, delivery system, and dispersion system . The payload is biological material consisting of an infectious agent (a pathogen) or a toxin produced by bacteria,· plants, or animals. The munition serves to containerize the payload to maintain its potency during delivery. The delivery system can be a missile, vehicle (aircraft, boat, automobile, or truck) , or an artillery shell that transports the payload to a susceptible target. The dispersion system, provided by an explosive force or spray mechanism, ensures dissemination of the payload at the intended target.
Although the list of potential agents is numerous, those that could cause mass casualties by aerosol exposure are considerably smaller (Burrows & Renner, 1998; Christopher, Cieslak, Pavlin, et al., 1997; Christopher & Eitzen, 1999 ; Department of the Army, the Navy, and the Air Force, February 1996; Eitzen, 1997; Eitzen, Pavlin, Cieslak, et al., 1998; Franz, 1997; Kottepeter & Parker, 1999; Peters & Dalrymple, 1990; Tempest Publications, 1998) . Infectious biological payloads that could potentially be used include those causing anthrax (Bacillus antbracis), plague (Yersinia pestis), tularemia (Francisella tularensis), equine encephalitides (Venezuelan equine encephalitis, eastern equine encephalitis, and western equine encephalitis viruses), hemorrhagic fevers (arenaviruses, filoviruses, flaviviruses, and bunyaviruses), and smallpox (variola virus) . Toxins include botulinum toxin from Clostridium botulinum; ricin toxin from the castor bean Ricinus communis; trichothecene mycotoxins from Fusarium. Myrotecium, Tricboderma, Stacbybotrys, and other filamentous fungi; staphylococcal enterotoxins from Staphylococcus aureus; and toxins from marine organisms such as dinoflagellates, shellfish, and blue-green algae. If these agents are delivered successfully to a susceptible host, a lethal or incapacitating outcome will occur, depending upon the agent. For ins tance, the most likely result from the agents causing anthrax and plague is death of the target host. Coxiella burnetii (the agent of Q~fever), staphylococcal enterotoxin B, and Venezuelan equine encephalitis virus are considered incapacitating agents. In a military context, incapacitating agents may be, in a certain sense, more effective because the affected unit will not be able to perform its mission and casualties will consume scarce medical and evacuation assets. In a biological terrorism scenario, both lethal and incapacitating agents could have an adverse impact on the civilian health care delivery system. Potential manifestations include terror in the affected population and in medical care personnel; an overwhelming number of casualties placing demands for ICU care or special medications; a need for personal protection in medical care settings, clinical laboratories, and autopsy suites; and problems with handling remains. Employing standard precautions or barrier nursing techniques (English, Cunidiff, Miller, et al., 1999) , depending on the agent, can provide appropriate (or adequate) protection against biological agents to health care providers. However, additional precautions such as aerosol, droplet, or contact protection are recommended in instances where smallpox, Y. pestis (plague), the hemorrhagic fever viruses, or T~2 mycotoxin are suspected. There may be a hazard of person-to-person transmission, transmission by direct contact with blood or body fluids, or dermal activity (Department of the Army, the Navy, and the Air Force, February 1996; Franz, 1997; Franz, [ahrling, Friedlander, et al., 1997; Gamer & Hosp. Infect. Control Pract, Advis, Comm., 1996; Gamer & Hosp. Infect. Control Pract. Advis, Comm., 1996; Wannemacher & Wiener, 1997) .
Historical Aspects
Biological weapons are not new, but nations have developed and perfected the technologies of production and delivery during the 20th century. For thousands of years, biological agents have been used as instruments of warfare and terror (bioterrorism), producing fear and harm in a vulnerable population. Targets have been humans as well as animals and plants. To initiate a plague epidemic during the 14th century siege of Kaffa, the attacking Tatar force catapulted the bodies of their deceased soldiers into the city. During the 1754~1767 French and Indian War, the British deliberately unleashed smallpox against Native American tribes, using fomites from an outbreak of smallpox at Fort Pitt.
On June 24, 1763, the immunologically na'ive Native Americans were given blankets and a handkerchief in an attempt to "reduce" tribes hostile to the British (Christopher, Cieslak, Pavlin, et al., 1997) .
During World War I Germany contaminated animal feed and infected livestock for export to Allied forces. They also planned to infect sheep from Romania with B. antbracis (anthrax) and Burkbolderia mallei (glanders) for export to Russia. German saboteurs operating in Mesopotamia allegedly were to use B. mallei to inoculate 4,500 mules and infect horses of the French cavalry in France . Livestock in Argentina, destined for export to Allied forces during 1917~1918, were infected with B. antbracis and B. mallei, resulting in the death of more than 200 mules (Christopher, Cieslak, Pavlin, et al., 1997) .
Japan conducted biological warfare experiments in Manchuria from 1932 to 1945 . At the infamous Unit 731, a biological warfare research facility near the town of Ping Fan, prisoners were infected with B. antbracis, Neisseria meningitidis, Shigella spp., B. mallei, Salmonella typhosa, Vibrio cholerae, Y. pestis, smallpox virus, and other diseasecausing agents (Harris, 1995) . In addition, a number of Chinese cities were attacked with biological warfare agents. The Japanese contaminated water supplies and food items with B. antbracis, Shigella spp., Salmonella spp., V, cholerae, and Y. pestis. Cultures were also tossed into homes and sprayed from aircraft. Potentially infected fleas were harvested in the laboratory and then as many as 15 million were released from aircraft during each attack. Because of the Japanese's inadequate preparation, training, and/or lack of proper equipment, however, the Chekiang Campaign in 1942 reportedly led to about 10,000 biological casualties and 1,700 deaths among the Japanese troops, most from cholera and some from dysentery and plague (Williams & Wall ace, 1989) .
Prisoners in Nazi concentration camps were forcibly infected with Rickettsia prowazekii, Rickettsia mooseri, hepatitis A virus, and Plasmodium spp., and also treated with investigational vaccines and drugs (Mitscherlich & Mielke, 1962) . In May 1945, the Germans polluted a large reservoir in northwestern Bohemia with sewage (Stockholm Int. Peace Res. Inst., 1971) , the only known tactical use of biological warfare by the Germans. For potential retaliatory use in response to a German biological attack, the British developed biological warfare capabilities by conducting bomb experiments with weaponized spores of B. anthracis on Gruinard Island near the coast of Scotland during 1941 and 1942. Viable anthrax spores persisted for 45 years after World War II until the island was decontaminated with formaldehyde and seawater in 1986 (Manchee & Stewart, 1988) .
The United States' offensive biological warfare program began in April 1943 at Camp Detrick, Maryland (renamed Fort Detrick in 1956) , with testing sites at Hom Island, Mississippi and Granite Peak, Utah (Endicott & Hagerman, 1998) . Experiments were conducted with B. anthracis and Brucella suis. A new production facility was constructed at Pine Bluff, Arkansas during the Korean War (1950) (1951) (1952) (1953) to meet projected demands. Human experiments were conducted at Camp Detrick with nonlethal agents in 1955. Volunteers' exposure to biological munitions containing F. tularensis and C. burtietii occurred in a 1 million-liter spherical aerosolization chamber when they put their face up to an opening in a portal for dosage studies. These studies were designed and conducted to determine the volunteers' vulnerability to aerosolized pathogens and the efficacy of the vaccines, prophylaxis, and therapies under development. Additional studies were done with the simulants Aspergillus fumigatus, B. subtilis var. globigii, and Serratia marcescens to determine production and storage techniques, aerosolization methods, the behavior of aerosols over large geographic areas, and the effects of solar irradiation and climatic conditions on the viability of aerosolized organisms.
During ·1952-1953, Moscow, Peking, and Pyongyang alleged that U.S. Armed Forces used biological weapons against targets in North Korea and China. Although these allegations were never conclusively proven and were denied by the U.S. Government, they caused the United States to lose international goodwill and many continue to believe that the United States used biological weapons during this time. The South China Morning Post also reported that Chinese officials accused the United States of plotting the cholera epidemic in the southeast province of Kwantung Province in the summer of 1961. The U.S. Department of State denied this accusation. In addition, the events in Brazil during 1957-1963 were reminiscent of the technique used by the British against Native American Indians in the 18th century. In a 1969 trial, the Brazilian Ministry of the Interior disclosed evidence of the deliberate use of smallpox, chickenpox, tuberculosis, influenza, and measles on several Indian tribes in the Mato Grosso. These agents were allegedly introduced in order to clear the Indian tribes from valuable rubber land.
During the 1962-1968 war in Indo-China, Viet Cong rebels used a crude biological weapon-spear traps and hidden bamboo spikes ("pungi sticks") tipped with animal or human excrement-to booby trap U.S. forces in Vietnam. These weapons caused percutaneous infection in those who came in contact with the spear traps and spikes . U.S. allegations of the use of aerosolized trichothecene mycotoxins ("yellow rain") in Laos (1975 Laos ( -1981 , Kampuchea (1979 Kampuchea ( -1981 , and Afghanistan (1979 Afghanistan ( -1981 by Soviet armed forces and their surrogates are unsubstantiated for many reasons (Christopher, Cieslak, Pavlin, et al., 1997) .
However, an interesting point must be raised regarding these allegations of biological weapons use by various factions or governments. Conclusive evidence is less likely to be found the longer the time period becomes between a report of the alleged use of a biological weapon and an investigation. Whatever the belief, there is some uncertainty of their use.
In 1978, an attempt to assassinate the Bulgarian exile Vladimir Kostov in Paris used ricin (the toxin extracted from castor beans). A ricin-containing pellet was discharged into his back from an umbrella gun, but because of his heavy clothing the pellet did not penetrate deep enough into his body for the wax pellet coat to melt. The Bulgarian exile Georgi Markov was assassinated 10 days later in London with a ricin-filled polycarbonate ball ). An umbrella gun discharged the pellet into the subcutaneous tissue of his ieg while he was waiting at a metro stop.
Despite care administered during his hospitalization, he died 3 days later .
Use, or the potential use, of biological weapons during the past 20 years has been exhaustively publicized, especially since the discovery of an extensive biological warfare program in Iraq after the Gulf War of 1991. Because of knowledge about a similar covert program in the former Soviet Union, (Alibek, 1999; Alibek, 1999) , considerable U.S. public attention has been focused on the use and consequences of a biological weapons encounter. In 1984, the Rajneeshee Cult, an Indian religious group, contaminated restaurant salad bars in Oregon with Salmonella typbimurium, and about 751 citizens were infected. The cult's motivation was to incapacitate voters in order to win a local election and to seize political control of Dalles and Wasco counties (Stem, 1999; Tucker, 1999) . In 1991, the Minnesota Patriots Council, a group of antigovernment tax protesters, planned to inoculate Internal Revenue Service officials, a U.S. Deputy Marshal, and local law enforcement officials with ricin. Their objective was to harm the federal government and obtain personal revenge (Tucker, 1999) . Larry Wayne Harris' motive was to alert Americans to the Iraqi biological warfare threat and establish a separate homeland for whites in the United States. He had links to Christian Identity and the Aryan Nation, a white supremacist group. Harris made vague threats against U.S. federal officials on behalf of right-wing "patriot" groups. He obtained the B. anthracis vaccine strain, Y. pestis, and reportedly several other bacteria and discussed the dissemination of biological warfare agents by means of crop duster aircraft and other methods. He was arrested in 1998 after he made threatening remarks to U.S. officials and openly talked about biological warfare terrorism (Tucker, 1999) .
Beyond the shores of the United States, the Aum Shinrikyo (Aum Supreme Truth) Cult wanted to establish a theocratic state in japan with a charismatic, power-hungry leader named Shoko Asahara. Its objective was to prove an apocalyptic prophecy, eliminate enemies and rivals, halt a 1994 adverse court ruling regarding a real estate dispute in Matsumoto, and seize control of the japanese government. In 1995, they also disseminated the chemical agent sarin (inhibits acetylcholinesterase, thereby disrupting nerve impulse transmission) in the Tokyo subway system. Aum Shinrikyo's multiple attacks with many chemical agents including hydrogen cyanide (prevents the normal utilization of oxygen) and VX (inhibits nerve impulse transmission), and assassinations in other areas of japan resulted in the injury of more than 1,000 persons and the deaths of at least 20 (Tucker, 1999) . These chemical agents can be incapacitating or lethal, depending upon the dosage. Targets of the Aum Shinrikyo Cult were mass civilian populations, individuals opposed to their ideology, and judges ruling against and police investigating the cult. In 1993, they attempted to obtain Ebola virus from Zaire, Africa and in 1994 discussed the possibility of using Ebola virus as a biological weapon. The cult also cultured and experimented with anthrax, Q-fever, cholera, and botulinum toxin (Olson, 1999; Tucker, 1999) .
Properties of Biological Agents
Biological agents may be used, perhaps as an ultimate weapon, because of several characteristics valued by the perpetrator. Aerosols of biological agents are invisible, silent, odorless, tasteless, and relatively easily dispersed without detection. They are also relatively inexpensive to produce, with the cost about 0.05% that of a conventional weapon capable of causing a similar number of mass casualties per square kilometer. In addition, their production follows common fermentation technology used to produce some antibiotics, vaccines, foods, and beverages. Basic, commonly available technology, such as spray devices from an airplane, boat, or car, is available for their delivery over large areas. Terrain, equipment, and infrastructure are usually spared because explosives are not normally used for the delivery of biological agents. Because of this simplicity, it is not difficult for users to tailor their arsenal to fit their needs.
Biological weapons can be used in combination with other weapons to create fear, terror, and panic and produce a large numbers of casualties. The consequences of their use are many. They may rapidly overwhelm medical resources, and because most agents have incubation times of several hours to days, the perpetrators could escape before any effects are even noticed. In addition, such endemic agents may cause confusion because it is difficult to differentiate a biological warfare attack from a natural epidemic, so, although limited, the potential exists for secondary or tertiary transmission.
Where can an individual or group obtain biological agents for use in biological warfare or develop biological weapons, and how can these agents be delivered to a susceptible target? Biological agents are available from multiple culture collections, universities, commercial chemical and biological supply houses, foreign laboratories, and field samples or clinical specimens. Aerosol delivery is considered optimal if the particle size is between 1 and 5 urn because particles with these characteristics will settle in the lower respiratory tract and be undetectable by our senses. Smaller particles will be exhaled because of the aerodynamics of particle flow through the respiratory tract; larger particles will settle on environmental surfaces or on the upper respiratory tract, allowing mucocilliary clearance. Delivery of a biological agent by an explosive device is not as effective as aerosol delivery because the heat and light from an explosion may inactivate the agent. Production of particles of 1-5 urn in size is inefficient in an ex, plosion. Good delivery methods include an open-air line source delivery system where a spray device is attached to a moving conveyance. An open-air point source delivery system employs a stationary device such as a sprayer, bombs, or bomblets (a device with a physical guidance system designed to disseminate the biological agent upon impact or at a predetermined altitude). Limited air-delivery applications include spray devices, bombs, or bomblets. Delivery in water supplies may not be effective because of the dilution factor and because water purification methods such as chlorine treatment, coagulation and flocculation methods, and reverse osmosis systems tend to inactivate microbial agents. However, in some circumstances, increased vigilance is needed, because the effectiveness of delivering a biological agentts) in water can be increased by delivering it at or near the source of consumption. Biological agents can also be delivered by direct application as in the case of assassination by pellets or flechettes (a dart-shaped projectile) (Eitzen, 1997) .
Properties of Personal Protection
How can we protect ourselves against biological warfare agents? The primary means of protecting both persons working with potentially hazardous biological materials and the environment in a laboratory or re, search setting are engineering controls combined with good laboratory and microbiological techniques and common sense. Equally important is the use of certain personal protective equipment and measures (such as an occupational health program) and decontamination procedures. Implementing protective measures and pro' cedures depends upon both the situation and their availability. Standard precautions (designed to reduce the risk of transmission of microorganisms from both recognized and unrecognized sources of infection) and protection against transmission by contact, droplet, and airborne vectors, where appropriate, should be em, ployed by all laboratory workers to prevent their expo' sure to potentially hazardous materials (Inglesby, Hen, derson, Bartlett, et al., 1999 Comm., 1996) combine the major features of universal precautions (blood and body fluid precautions designed to reduce the risk of transmission of bloodborne pathogens) and body substance isolation (designed to reduce the risk of transmission of pathogens from moist body substances).
Engineering controls (Title 32 Cod of Federal Regulations, 2000) refer to those barriers applied at the hazard's point of origin. The most important primary barriers are biological safety cabinets, some form of ani, mal cage containment (cage tops with filters and laminar flow enclosures), and positive-pressure protective suits. Biological safety cabinets (e.g., Class I, II, and III cabinets) are the most effective and most commonly used primary containment devices in laboratories work, ing with infectious agents (Richmond & McKinney, 1995; . Incorporating charcoal filters in the exhaust system of cabinets makes them suitable for use with toxins suspended in volatile material. In situations where the agent is highly hazard, ous (and where there are no other protective measures, such as a vaccine, against the agent), laboratory workers are physically protected by a positive-pressure pro' tective suit, a type of primary barrier, in biosafety level, 4 (BSL,4) laboratories.
Secondary barriers against biological agents include design features that protect individuals inside and out, side the facility. These barriers vary depending upon the hazards presented by the agents and materials and the laboratory procedures used in the facility . Secondary barriers may include physical barriers in the laboratory or research facility (such as limited access, separate room entry' areas, personnel airlocks, or change rooms), directional air flow of nonrecirculated air, and discharge of exhaust air remote from occupied areas and air int akes. Exhaust air must be filtered through one or more high-efficiency parriculate air (HEPA) filters in series with certain infectious agents or at biosafety level 4. HEPA filters are constructed of paper-thin sheets of borosilicate medium, pleated to increase surface area with aluminum separators for added stability, and affixed to a frame. A HEPA filter removes parriculate material the size of 0.3 urn or greater with a minimum efficiency of 99.97% (Rayburn, 1990; Title 32 Cod of Federal Rgulations, 2000) . Other forces, such as electrostatic charge and the effects of filtration velocity, impaction, and entrapment, affect filtration efficiency of particles smaller than 0.3 urn. Additional batriers include nonionizing ultraviolet (uv) light irradiation (which is lethal to a wide variety of bacteria and viruses, but its effectiveness depends on the intensity and length of exposure); sinks for hand-washing; screened or sealed windows; equipment for decontamination and disposal of hazardous materials; work surfaces amenable to cleaning, housekeeping, and decontamination; and personal protective equipment (PPE).
PPE includes clothing and equipment used to proteet individuals in a laboratory or research environment from contact with infectious or toxic materials or physical hazards. The appropriate PPE for an activity depends upon the operations conducted and the potential hazards associated with the activity. It must be emphasized that PPE, although an important item of personal protection, serves only as a secondary barrier against hazards in the laboratory or research environment. Proper PPE must be carefully chosen to mitigate the hazards presented by the agents and procedures used. To assist in the selection of appropriate PPE, workers should consult agent summary statements , agent manuals (Chin & Ascher, 2000) , material safety data sheets (when handling hazardous or potentially hazardous chemicals), facility standard operating procedures, and persons knowledgeable about the associated hazards, such as facility safety personnel. At a minimum, with con-sideration of the risks involved, PPE may include street attire protected by a full-length, long-sleeved, fully fastened laboratory coat, gown, or smock; closed-toe shoes; eye protection; ear protection; molded "surgical type" masks (filtering facepiece): appropriate gloves ("examination" or "surgical" type depending upon the need for sterile procedures); and HEPA~filtered respirators. Although HEPA filters used in respirators are not certified by the National Institute of Occupational Safety and Health (NIOSH) for use in a biological environment , these filters have been suecessfully used to protect personnel for many years.
Personal protective measures also include elements of an occupational health program. One element is medical surveillance, during which a physician determines if an individual is medically qualified to work with potential occupational hazards. Another element is the collection and storage of baseline serum samples, when appropriate, from individuals handling certain hazardous agents or those participating in a special immunizations program. The occupational health prog ram should evaluate personnel's physical and mental suitability for assignment to areas where certain hazardous agents are handled. Another element of the program is to vaccinate at-risk personnel, those who may be occupationally exposed to certain agents. If a safe vaccine is available for the agentts) being used and is known to protect against the agentts), it should be provided for those individuals working directly with the agentls) and for other at-risk personnel (such as facility maintenance, animal care, and safety personnel). The program should also include a mechanism for the immediate reporting of potential exposures to agents, such as mishaps, spills, or other accidents. It is also ext remely important to report any illness associated with working with these agents, no matter how remote the possibility of exposure may seem or even if an incident cannot be associated with the illness. Each exposure, or potential exposure, should be evaluated by appropriate medical staff and, if required, treated. Medical treatment of individuals potentially exposed to biosafety level 2, 3, or 4 agents can be safely accomplished by standard or transmission-based (airborne, droplet, or contact) precautions where appropriate (Gamer, & Hosp. Infect. Control Pract. Advis. Comm., 1996; Garner, & Hosp. Infect. Control Pract. Advis. Comm., 1996) . The availability of a quarantine facility with a capability for isolation and medical care of personnel with a potential or known laboratory-associated exposure is required for Army facilities handling BSL-4 (maximum containment) agents (Title 32 Code of Federal Regulations, 2000).
Decontamination
Decontamination procedures in a laboratory or research environment vary depending upon the capabilities of the facility and the agentts) used (Bloomfield & Uso, 1985; Eitzen, Pavlin, Cieslak, et aI., 1998;  McDonnell & Russell, 1999; Russell, 1990; Rutala & Weber, 1997 ). Decontamination is disinfection or sterilization of articles containing etiologic agents (microorganisms or toxins) to make them safe for use or disposal. Disinfection is the selective elimination of certain undesirable microorganisms to prevent their transmission. Sterilization is the complete destruction of microbial life Eitzen, Pavlin, Cieslak, et al., 1998; Rutala & Weber, 1997) .
Decontamination procedures can be discussed from two approaches: surface decontamination and area (space) decontamination. For surface decontamination, the effectiveness of a decontaminant depends upon its concentration, the concentration of the agent, type of agent, time of contact, and the environmental conditions (Jones, Hoffman, & Phillips, 1968; Malloch & Stoker, 1952; Scott & Williams, 1990; Wickramanayake & Sproul, 1991) . There are a number of general groups of decontaminants include alcohols, halogens, quaternary ammonium compounds, phenolics, and glutaraldehyde. Many of these decontaminants (Alasri, Valverde, Roques, et aI., 1992) are active only against certain groups of microorganisms while inactive against others. These decontaminants are used primarily for the interior of safety cabinets, room surface washdowns, wiping off the exterior of certain items removed from laboratories, and in chemical disinfectant showers used to disinfect a positive-pressure protective suit. Some halogen-containing decontaminants are corrosive. There is an association between autoclave corrosion and the use of halogenated disinfectants, particularly chlorine disinfectants. Chlorine may combine with organic materials during autoclaving. The resulting compound, or compounds, is corrosive in autoclaves, drains, vents, and the central vacuum and receiver system that supports the autoclaves. The actrvity of chlorinecontaining disinfectants, such as sodium hypochlorite solution, can be neutralized with sodium thiosulfate.
The second approach to decontamination is area or space decontamination, that is, decontamination of equipment or materials within enclosed spaces. This can be achieved by using a variety of gases (Parisi & Young, 1991) . Ethylene oxide (epoxyethane, ETa) is a flammable and explosive gas, classified as both a mutagen and a carcinogen. The microbicidal activity of ETa is due to alkylation of sulfhydryl, amino, carboxy, phenolic, and hydroxyl groups in the spore or vegetative cell. The reaction of ETa with nucleic acids is the primary mechanism of its bactericidal and sporicidal activity. ETa is used because of its ability to inactivate most bacteria, molds, yeasts, and viruses, but its use is limited because of the many dangers mentioned. Propylene oxide (epoxy propane) hydrolyzes in the presence of moisture to form propylene glycol; which is nontoxic. Propylene glycol vapor (Puck, Robertson, & Lemon, 1943) is odorless, tasteless, and nonirritating to the respiratory mucosa. The microbicidal mode of action of propylene oxide is the alkylation of DNA guanines resulting in single-strand breaks. Betapropiolactone (BPL) is approximately 4,000 times more active than ETa and 25 times more effective than formaldehyde. The microbiological activity of BPL is due to alkylation of DNA. However, this decontaminant is used infrequently because BPL lacks the ability to penetrate material and is carcinogenic in mice. Formaldehyde is more widely recognized as a fumigant for buildings and rooms (Songer, Braymen, Mathis, et aI., 1972; Taylor, Barbeito, & Gremillion, 1969) . Formaldehyde gas is capable of killing microorganisms and detoxifying Clostridium botulinum toxin. The microbicidal activity of formaldehyde results from the denaturation of proteins. Ammonium bicarbonate can be used to neutralize formaldehyde gas. Although formaldehyde vapor is explosive at concentrations between 7.0%-73.0% by volume in air, these concentrations should not be reached if standard decontamination procedures (using 0.3-0.6 gift: of parsformaldehyde in the presence of 60%-90% relative humidity) are used.
The most commonly recommended decontaminant for an area is formaldehyde. It is used to decontaminate biological safety cabinets (Fink, Liberman, Murphy, et aI., 1988) , laboratory rooms, laboratory areas, and equipment in airlocks. Although widely used and recommended as a surface and area sterilant, formaldehyde is a safety hazard because it is a potential occupational carcinogen. In addition, it is a powerful reducing agent, has limited penetrating ability, and is potentially explosive. Environmental release of formaldehyde is also highly regulated. For these reasons, technologies that may provide alternative sterilants are emerging. One alternative is the powerful oxidant chlorine dioxide, which is an effective sterilant even at concentrations as low as 20 mg/l. A relative humidity of 50% or higher is optimal for sterilization. Another alternative, ozone, is not a new sterilant; it was 'used to sterilize the water supply of Lille, France in 1899. It has potential as a sterilant for medical devices because it is highly oxidizing. The alternative gas plasma sterilization process uses radio frequency energy and hydrogen peroxide vapor to create a low,temperature hydrogen peroxide gas plasma to achieve relatively rapid sterilization. Radio waves break apart the hydrogen peroxide vapor into reactive species (free radicals), which form a gas plasma that interacts with and kills microorganisms. The ad, vantage of this process is that the process temperature does not exceed 40°C.
A relatively new alternative sterilization system is based on the vapor phase of hydrogen peroxide . The system provides a rapid, low,temperature technique that, because of its low toxicity, eliminates much of the potential public health hazard associated with decontaminants such as formaldehyde and ethyl, . ene oxide. In the cold sterilization process, 30% liquid hydrogen peroxide (300,000 ppm) is vaporized to yield 700,1,200 ppm. The hydroxyl radical, a strong oxidant, is believed to have microbicidal activity through attack on membrane lipids, DNA, and other essential cell components. The hydrogen peroxide vapor is unstable and degrades to the nontoxic residues of water vapor and oxygen. Any sealable enclosure, such as small rooms, airlocks, biological safety cabinets, glove boxes, and isolation equipment, (up to 1,200 fr') can be sterilized. The process is effective at temperatures ranging from 4°C to 80°C. The vapor phase hydrogen peroxide sterilization system appears to be safe and is effective against a variety of microorganisms. The range of etiologic agents inactivated by various decontamination techniques is extensively documented (Alasri, Val, verde, Rogues, et al., 1992; Bloomfield & Uso, 1985; McDonnell & Russell, 1999; Parisi & Young, 1991; Puck, Robertson, & Lemon, 1943; Russell, 1990; Rutala & Weber, 1997; Songer, Braymen, Mathis, et al., 1972; Wickramanayake & Sproul, 1991) .
Protection During a Response to an Incident
During a response to an incident involving biological agents, or during work in the field, it is anticipated that only personal protective measures and equipment and decontamination procedures may be available to personnel. Protection against biological agents can usually be provided by PPE used to protect against hazard, ous chemicals. As in a laboratory or research environ, ment, it is important to consider the hazard when se, lecting PPE in a field environment. The availability and procedures for the use of protective equipment against biological agents by military personnel in a combat environment is well documented (Department of the Army, the Navy, and the Air Force, February 1996; Field Manual 3,4, 1992) . Personnel trained in microbiology and biological safety are essential re, sources in providing support to law enforcement agencies in response to an actls) of bioterrorism or an incident involving biological weapons. These professionals will be able to practically apply the principles of biosafety during a terrorism incident. An immediate evaluation of the situation is foremost and is accomplished by employing risk management procedures following the guidelines for conducting a risk assessment (Army Regulation 385,10,2000; Fleming, 2000; Ham, mer, 1989; Sidell, Patrick, & Dashiell, 1998; Tempest Publications, 1998) . Risk management is the systematic application of policies, practices, and resources to the assessment and control of risk affecting human health, human safety, and the environment. Risk assessment is an expression of potential loss in terms of hazard sever, ity, accident probability, and exposure to the hazard. One must consider the severity of the hazard by assess, ing the expected consequence, which is defined as the degree of injury or occupational illness that could occur from the hazard. The probability of an accident or ill, ness occurring after a given exposure to the hazard must also be determined. Finally, exposure to the hazard considers the number of persons exposed and the dura, tion or frequency of the exposure. A risk assessment guides the choice of appropriate PPE for responding personnel and subsequent management of those potentially exposed to a threat agent. A risk assessment is never completed. It is a constant review of implemented procedures, policies, and plans, and reduces all hazards to the lowest acceptable level.
Levels of protection for a hazardous chemical incident (Table 1) are categorized from levels A (maximum protection) through D (limited protection). Level A provides the highest level of respiratory, skin, and eye protection. Level B provides the highest level of respiratory protection but less skin protection. Level C is used when the concentration and identification of the air contaminant is known so that an appropriate NIOSH,approved air-purifying respirator can be used. Level D protection can be used where the atmosphere is free of all known hazards and the tasks do not pose a splash, immersion, or potential respiratory hazard.
Level 0 is comparable to PPE worn in a hospital laboratory-a hospital gown or laboratory coat, goggles, sur, gical mask, and latex examination or surgical gloves. Depending on the hazard, protection afforded by Level CorD may be adequate for emergency response per, sonnel or in a field environment. Where the hazard lingers, is concentrated, and may be volatile, protection against biological agents can be provided by employing standard precautions or barrier nursing tech, niques, depending on the biological agent (English, Cunidiff, Miller, et al., 1999; Inglesby, Henderson, Bartlett, et al., 1999; . Individuals will be protected against the potential of person,to,person transmission of the agenrts) and any environmental biological hazards. The rationale is that biological agents, in most situations, would most likely be dis, persed from the area before the arrival of personnel (Henderson, 1999; . However, additional precautions such as respiratory and cutaneous protection are recommended in certain instances where smallpox, Y. pestis, the hemorrhagic fever viruses, or T, 2 mycotoxin are suspected, and where there may be a hazard of person-to-person transmission, transmission by direct contact with blood or body fluids, or dermal activity (Franz, 1997; Franz, [ahrling, Friedlander, et al., 1997 ; NATO Handbook on the Medical Aspects of NBC Defensive Operations, 1996; Wan' nemacher & Wiener, 1997) .
During a response to an incident or in a field environment involving biological agents, protection against biological warfare agents can also be accomplished by implementing decontamination procedures (Eitzen, Pavlin, Cieslak, et al., 1998; Hurst, 1997; using mechanical (physical) and chemical methods. A medical or patient decontamination process is for Table 1 Levels of Protection-Hazardous Chemical Incident Description of Protective Equipment Self-contained breathing apparatus (SCBA) or supplied air with a NIOSH,approved escape pack and a fully encapsulated suit and undergarment with appropriate protective gloves, shoes, and head cover SCBA or supplied air with an escape pack, a chemical-resistant suit, and appropriate protective gloves, shoes, and head cover Chemical,resistant when the contaminant will not adversely affect exposed skin or be absorbed through the skin; appropriate protective gloves, shoes, and head cover; optional use of a face shield, goggles, or safety glasses with side shields Escape mask, if required, and a work uniform or coveralls and protective gloves and shoes. Increased protection can be afforded with head protection, a face shield, and goggles or safety glasses with side shields. [Hospital gown or laboratory coat, goggles, surgical mask, and latex examination or surgical gloves.] cleaning injured or exposed individuals . To decontaminate vehicles and PPE, a technical de, contamination process for gross biological contamination is used. The sequential, nine,step technical decontamination process, used by the public service community, was developed in 1995 . Depending upon the contaminant, four cleaning solutions (known as A, B, C, and D) are used with water to effect decontamination. For technical biological decontamination, a 10% solution of sodium hypochlorite (Solution B) is used . Some prefer a 10% solution of calcium hypochlorite as Solu-tionB because an effective concentration can be achieved and it has a longer shelf life than sodium hypochlorite (M. S. Hildebrand, personal communication). describe details of this technical decontamination process.
Level of Protection
Decontamination of equipment or fabric clothing is accomplished with a 30,minute contact with a 5% sodium hypochlorite solution, followed by cleaning with soap and water. Because this procedure is corrosive to metal and fabrics, a thorough water rinse is recommended after decontamination, followed by a process to preserve the treated item (Eitzen, Pavlin, Cieslak, et al., 1998) . Patient or medical decontamination is required . when the biological agent (contaminant) places the exposed individual at further risk or presents a potential secondary risk to other personnel. The emerging consensus (Eitzen, 1999; Keim & Kaufmann, 1999; Richards, Burstein, Waeckerle, et al., 1999) is that decontamination of persons exposed to a potential biological aerosol is probably unnecessary and that, at most, removal of clothing and a soap and water shower are perfectly adequate to prevent secondary exposures. Based on the available evidence (Hurst, 1997; Keim & Kaufmann, 1999) , reaerosolization of biological agents from clothing or skin does not appear to be a major is, sue. In most circumstances, health care providers and first responders are not at risk from such a hazard.
The efficacy of decontamination of inanimate sur, faces with liquid household bleach is documented in recent experiments conducted at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) (Hawley & Nash, unpublished observations). Undiluted liquid household bleach inactivated 110 99.8% of the spore population (a 5 logio reduction in viability) of B. antbracis after 1 minute of contact time.
Similarly, after 1 minute of contact, an E coli population was completely inactivated (a 6 loglO reduction in viability). E. coli was used as a gram-negative model in these experiments to simulate Y. pestis and other gram, negative bacteria that are more fastidious in their growth requirements and more dangerous to handle. Further experiments were conducted to determine the efficacy of 0.26% sodium hypochlorite (a 1:20 dilution of liquid household bleach, 2,625 parts per million free, available chlorine). Results showed a 100% inactivation of the spore population (a 5 loglO reduction in vi, ability) of B. antbracis after 15 minutes of contact with 0.26% sodium hypochlorite. Using 0.5% sodium hypochlorite (a 1:9.5 dilution of liquid household bleach, about 5,500 parts per million free, available chlorine), a greater than 90% inactivation of the spore population (up to a 3 logio reduction in viability) of B. antbracis was observed after 5 minutes of contact time. Experiments are in progress to refine the contact time data for inactivating B. antbracis spores and to determine the influence of extraneous organic material on inactivation kinetics.
After an aerosol incident with a biological agent, it is believed that only very minimal contamination of the clothing or skin of victims occurs. In addition, de, contamination of victims can be accomplished (if even necessary) by removing their clothing and having them shower at home with soap and water (Eitzen, 1999; In, glesby, Henderson, Bartlett, et al., 1999; Keim & Kaufmann, 1999; Richards, Burstein, Waeckerle, et al., 1999) . Reaerosolization of a biological agent in a hospital setting is unlikely (Eitzen, 1999; English, Cunidiff, Miller, et al., 1999 ; NATO Handbook on the Medical Aspects of NBC Defensive Operations, 1996; . Essential resources for first responders, lawen, forcement agencies, and the medical community during incidents involving biological weapons include microbiologists, biosafety professionals with a strong foundation in microbiology, and a designated clinical microbiology laboratory (Snyder, 1999) . The continuing education of medical responders is also an important com, ponent of this response network (Eckstein, 1999; Eitzen, 1999; Pesik, Keim, & Sampson, 1999) .
Response Issues
However, in a field environment or during res ponse to a biological weapons incident, only personal protective measures, equipment, and decontamination procedures may be available to personnel. In response to such a scenario, the Centers for Disease Control and Prevention (CDC) developed a strategic plan to address the deliberate dissemination of biological or chemical agents and to reduce United States' vulnerability to biological and chemical terrorism. The plan includes preparedness training, detection, and surveillance; laboratory analysis; emergency response; and communication systems. For the diagnosis and characterization of biological and chemical agents, the CDC and its partners have created a multilevel laboratory response network for bioterrorism. Its purpose is to link clinical laboratories to public health agencies in all states, districts, selected cities, and countries, as well as to state-of-the-art facilities that can analyze biological agents. The CDC will transfer diagnostic technology to state health laboratories and others who will perform initial testing. It will also create an in-house, rapidresponse, and advanced technology laboratory to provide around-the-clock diagnostic confirmatory and reference support for terrorism response teams (Kahn & Sage, 2000) .
"Local" clinical microbiology laboratories will play an essential role in the initial recognition of a biological weapons incident. They will be challenged to apply procedures for the isolation, rapid detection, and subsequent identification ) of a potential threat agentls) in a suspect samplers). Sample analysis data from the clinical microbiology laboratory will then provide guidance to first responders and health care providers for environmental and expedient patient management, respectively..
The medical community must also be responsive to any biological weapons incident. Its response must include prompt identification of the biological agentls) by the clinical laboratory or laboratory response network, and notification of local, state, and federal health and law enforcement agencies. The medical community must also be able to provide support to health care providers who may be overwhelmed with caring for large numbers of infected or intoxicated casualties (Leach & Ryman, 2000) . In fact, medical examiners and coroners may be the first to recognize unusual deaths due to a biological weapons incident, even before the medical community becomes involved (Nolte, Yoon, & Pertowski, 2000) .
Both the microbiologist and the biological safety professional should be able to apply most of the principles of biosafety and provide responsible officials with a practical assessment of the biological weapons incident situation. Their knowledge is crucially important in helping to address microbiology and safety issues, minimizing the fear and concerns of those responding to the incident, and helping to manage individuals potentially exposed to a threat agent.
